NorthStar inks Ac-225 supply deal with Clovis

2018 04 24 20 24 4264 Isotope 400

NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

Under the terms of the deal, NorthStar will provide Clovis with its no-carrier-added Ac-225. Clovis will use Ac-255 to radiolabel its peptide-targeted radionuclide therapeutic candidate, FAP-2286, which is in development and targets fibroblast activation protein (FAP).

Page 1 of 436
Next Page